The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.
D000328:Adult; D000367:Age Factors; D001369:Axons / Q000187:drug effects; D001706:Biopsy; D001932:Brain Neoplasms / Q000188:drug therapy; D002467:Cell Nucleus; D004576:Electromyography; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D007866:Leg; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009135:Muscular Diseases / Q000139:chemically induced*; D009210:Myofibrils / Q000187:drug effects; D009336:Necrosis; D009410:Nerve Degeneration; D009886:Ophthalmoplegia / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D010587:Phagocytosis; D012583:Schwann Cells / Q000187:drug effects; D014750:Vincristine / Q000009:adverse effects*; D014826:Vocal Cord Paralysis / Q000139:chemically induced
D014750:Vincristine